Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-24 Purchase |
2025-01-02 08:58 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
2,299 | $2.87 | $6,598 | 262,000 (Direct) |
View |
2024-08-27 Purchase |
2024-09-12 3:23 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
5,101 | $3.37 | $17,190 | 259,701 (Direct) |
View |
2024-06-21 Purchase |
2024-07-02 11:47 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
1,600 | $2.8 | $4,480 | 254,600 (Direct) |
View |
2023-12-27 Purchase |
2024-01-03 11:48 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
2,700 | $4.76 | $12,852 | 253,000 (Direct) |
View |
2023-12-14 Purchase |
2023-12-18 5:30 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
900 | $4.92 | $4,428 | 250,300 (Direct) |
View |
2023-12-06 Purchase |
2023-12-11 2:04 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
1,500 | $5.07 | $7,605 | 249,400 (Direct) |
View |
2023-09-11 Purchase |
2023-09-18 10:04 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
1,500 | $5.43 | $8,145 | 247,900 (Direct) |
View |
2023-08-28 Purchase |
2023-09-05 07:43 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
3,400 | $4.69 | $15,946 | 246,400 (Direct) |
View |
2023-08-18 Purchase |
2023-08-28 10:13 am |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
8,000 | $4.32 | $34,560 | 243,000 (Direct) |
View |
2023-08-21 Purchase |
2023-08-23 8:14 pm |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Shmerling James E. Director |
6,864 | $4.35 | $29,858 | 23,756 (Direct) |
View |
2023-04-06 Purchase |
2023-04-10 5:00 pm |
Biostage Inc. | BSTG | DST Capital LLC 10% Owner |
62,500 | $6 | $375,000 | 3,896,547 (Indirect Direct) |
View |
2022-12-12 Sale |
2023-01-05 2:26 pm |
Biostage Inc. | BSTG | He Junli Director |
135 | $6.83 | $922 | 235,000 (Direct) |
View |
2022-12-07 Sale |
2022-12-09 5:21 pm |
Biostage Inc. | BSTG | DST Capital LLC 10% Owner |
1,952 | $7.17 | $13,996 | 3,663,325 (Direct) |
View |
2022-12-07 Sale |
2022-12-09 5:21 pm |
Biostage Inc. | BSTG | Yu Hong PRESIDENT |
83,676 | $7.17 | $599,957 | 266,979 (Indirect Direct) |
View |
2022-12-07 Sale |
2022-12-09 5:19 pm |
Biostage Inc. | BSTG | Chen Jing Director |
48,532 | $7.17 | $347,974 | 161,468 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-09-03 Option Award |
2024-09-26 09:33 am |
N/A 2034-09-03 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Zhang Mao Director |
7,198 | $0 | 7,198 (Direct) |
View |
Ownership |
2024-09-26 09:27 am |
N/A N/A |
Harvard Apparatus Regenerative Technology Inc. | HRGN | STELLARS CAPITAL PRIVATE I Ltd Zhang Mao 10% Owner |
0 | $0 | 2,113,784 (Indirect) |
View |
2024-07-08 Other |
2024-08-07 6:29 pm |
2021-06-17 2026-06-17 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | DST Capital LLC 10% Owner |
215,000 | $0 | 3,781,547 (Direct) |
View |
2024-06-27 Option Award |
2024-07-15 11:14 am |
N/A 2034-06-27 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Packard Ronald J Director |
18,419 | $0 | 18,419 (Direct) |
View |
2024-06-27 Option Award |
2024-07-15 11:12 am |
N/A 2034-06-27 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Li Ting Director |
18,419 | $0 | 18,419 (Direct) |
View |
2024-06-27 Option Award |
2024-07-15 11:11 am |
N/A 2034-06-27 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Shmerling James E. Director |
18,419 | $0 | 18,419 (Direct) |
View |
2024-06-27 Option Award |
2024-07-15 11:10 am |
N/A 2034-06-27 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Sanchez Herman Director |
18,419 | $0 | 18,419 (Direct) |
View |
2024-06-27 Option Award |
2024-07-15 11:09 am |
N/A 2034-06-27 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | GREEN DAVID Director |
18,419 | $0 | 18,419 (Direct) |
View |
2024-06-27 Option Award |
2024-07-15 11:07 am |
N/A 2034-06-27 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Chen Jing Director |
18,419 | $0 | 18,419 (Direct) |
View |
2024-01-11 Option Award |
2024-01-12 8:09 pm |
N/A 2034-01-11 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO |
220,640 | $0 | 220,640 (Direct) |
View |
2023-07-26 Option Award |
2023-07-28 4:00 pm |
N/A 2033-07-26 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Chen Jing Director |
13,088 | $0 | 13,088 (Direct) |
View |
2023-07-26 Option Award |
2023-07-28 4:00 pm |
N/A 2033-07-26 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Sanchez Herman Director |
13,088 | $0 | 13,088 (Direct) |
View |
2023-07-26 Option Award |
2023-07-28 4:00 pm |
N/A 2033-07-26 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Li Ting Director |
13,088 | $0 | 13,088 (Direct) |
View |
2023-07-26 Option Award |
2023-07-28 4:00 pm |
N/A 2033-07-26 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Shmerling James E. Director |
13,088 | $0 | 13,088 (Direct) |
View |
2023-07-26 Option Award |
2023-07-28 4:00 pm |
N/A 2033-07-26 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | Packard Ronald J Director |
13,088 | $0 | 13,088 (Direct) |
View |
2023-07-26 Option Award |
2023-07-28 4:00 pm |
N/A 2033-07-26 |
Harvard Apparatus Regenerative Technology Inc. | HRGN | GREEN DAVID Director |
13,088 | $0 | 13,088 (Direct) |
View |
2023-04-10 Option Award(A) |
2023-07-10 3:47 pm |
N/A 2033-04-10 |
Biostage Inc. | BSTG | He Junli CEO |
267,616 | $0 | 267,616 (Direct) |
View |
2023-04-12 Option Award |
2023-05-02 11:52 am |
N/A 2033-04-12 |
Biostage Inc. | BSTG | Packard Ronald J Director |
4,839 | $0 | 4,839 (Direct) |
View |
2023-04-10 Option Award |
2023-04-12 11:24 am |
N/A 2033-04-10 |
Biostage Inc. | BSTG | He Junli CEO |
1,220,640 | $0 | 1,220,640 (Direct) |
View |
2023-04-06 Other |
2023-04-10 5:00 pm |
2021-09-01 2026-09-01 |
Biostage Inc. | BSTG | DST Capital LLC 10% Owner |
110,000 | $0 | 3,896,547 (Direct) |
View |
2023-02-28 Option Award |
2023-03-02 8:00 pm |
N/A 2033-02-28 |
Biostage Inc. | BSTG | GREEN DAVID CEO as of 2/28/2023 |
810,819 | $0 | 810,819 (Direct) |
View |
2023-01-25 Option Award |
2023-01-27 10:52 am |
N/A 2033-01-25 |
Biostage Inc. | BSTG | GREEN DAVID CEO |
47,651 | $0 | 47,651 (Direct) |
View |
2022-12-07 Exercise |
2022-12-09 5:21 pm |
2017-12-27 2022-12-27 |
Biostage Inc. | BSTG | DST Capital LLC 10% Owner |
7,000 | $0 | 3,663,325 (Direct) |
View |
2022-12-07 Exercise |
2022-12-09 5:21 pm |
N/A N/A |
Biostage Inc. | BSTG | DST Capital LLC 10% Owner |
7,000 | $2 | 3,663,325 (Direct) |
View |
2022-12-07 Exercise |
2022-12-09 5:21 pm |
2017-12-27 2022-12-27 |
Biostage Inc. | BSTG | Yu Hong PRESIDENT |
300,000 | $0 | 266,979 (Indirect) |
View |
2022-12-07 Exercise |
2022-12-09 5:21 pm |
N/A N/A |
Biostage Inc. | BSTG | Yu Hong PRESIDENT |
300,000 | $2 | 266,979 (Indirect) |
View |
2022-12-07 Exercise |
2022-12-09 5:19 pm |
2017-12-27 2022-12-27 |
Biostage Inc. | BSTG | Chen Jing Director |
174,000 | $0 | 161,468 (Direct) |
View |
2022-12-07 Exercise |
2022-12-09 5:19 pm |
N/A N/A |
Biostage Inc. | BSTG | Chen Jing Director |
174,000 | $2 | 161,468 (Direct) |
View |
2022-08-08 Option Award |
2022-08-09 6:06 pm |
N/A 2032-08-08 |
Biostage Inc. | BSTG | DAMASIO JOSEPH LUIS JR Chief Financial Officer |
116,156 | $0 | 116,156 (Direct) |
View |
2022-06-29 Option Award |
2022-07-01 5:59 pm |
N/A 2032-06-29 |
Biostage Inc. | BSTG | Shmerling James E. Director |
11,257 | $0 | 11,257 (Direct) |
View |